Currently, there is no cure for ACHM, but new treatment strategies are being developed, including adeno-associated virus-based gene supplementation therapy, in which the WT CNGA3 subunit is overexpressed in diseased cone photoreceptors5,39–43. Here, CNGA3 is linked to achromatopsia.